However, the relationship between the degree of CD8+ T cell infiltration and the ICB therapeutic responses in ccRCC remains unclear, perhaps because CD8+ T cell infiltrated ccRCCs are enriched with 9p21.3 deletions and relatively depleted PBRM1 mutations (26). This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.